---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-24-000009"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T21:50:47.546069+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Supernus SVP Regulatory Affairs retires; successor Roman Bradel to join in March 2024

## Summary
- Tami T. Martin notified retirement effective May 3, 2024.
- Roman Bradel expected to join March 2024 as VP Regulatory Affairs.
- Bradel will report to Frank Mottola, SVP Quality, GMP Operations and IT.

## SEC filing metadata
- accession: 0001356576-24-000009
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/0001356576-24-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/supn-20240214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-24-000009
- JSON: https://secwatch.observer/filing/0001356576-24-000009.json
- Plain text: https://secwatch.observer/filing/0001356576-24-000009.txt

## Key facts
- Executive change
  Roman Bradel was appointed as Vice President, Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC..
  - Action: appointed
  - Role: Vice President, Regulatory Affairs
  source text: The Company expects Roman Bradel, Ph.D. to join the Company in March 2024 as its Vice President, Regulatory Affairs reporting to Frank Mottola, the Company’s Senior Vice President, Quality, GMP Operations and IT.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/0001356576-24-000009-index.htm
- Executive change
  Tami T. Martin retired as Senior Vice President, Regulatory Affairs at SUPERNUS PHARMACEUTICALS, INC..
  - Action: retired
  - Role: Senior Vice President, Regulatory Affairs
  source text: Tami T. Martin, R.N., Esq., the Company’s Senior Vice President, Regulatory Affairs, notified Supernus Pharmaceuticals, Inc. (“Supernus” or the “Company”) of her retirement from the Company effective May 3, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000009/0001356576-24-000009-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.